Royal Bank of Canada
MDCX

Royal Bank of Canada’s Medicus Pharma MDCX Stock Holding History

Royal Bank of Canada’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+1,055
New +$374 ﹤0.01% 7936
2025
Q1 		– Sell
-17,100
Closed -$42K – 7343
2024
Q4 		$42K Buy
+17,100
New +$43.4K ﹤0.01% 5780

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Royal Bank of Canada's MDCX Position: Q2 2026 in Review

Royal Bank of Canada opened a new position in Medicus Pharma (MDCX) in Q2 2026: 1,055 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7936 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in MDCX as recently as Q4 2024.

Royal Bank of Canada first reported a position in MDCX in Q4 2024 and has held it in 2 quarters since. The position peaked at $42K in Q4 2024. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Royal Bank of Canada held 1,055 shares of Medicus Pharma worth $0 as of Q2 2026.
  • Medicus Pharma was a new Royal Bank of Canada position in Q2 2026.
  • Medicus Pharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7936 holding.
  • Royal Bank of Canada first reported a position in Medicus Pharma in Q4 2024 and has held it in 2 quarters since.
  • Royal Bank of Canada's Medicus Pharma position peaked at $42K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.